Partitioning determines how molecules distribute between neighboring phases or materials at an interface. A substance’s movement therefore depends not only on its presence in one compartment, but also on how readily it enters and remains in the adjacent compartment. In clinical systems, this behavior helps explain differences in drug absorption, distribution, and release across membranes, vessels, tissues, and biomaterial surfaces.
Diffusion moves molecules or ions through concentration-driven redistribution, whereas convection carries fluids and the substances within them. Both mechanisms can contribute to transport at clinical interfaces, but they describe different routes of movement. Distinguishing them helps researchers interpret exchange across cell membranes, blood vessels, and tissue barriers and assess how substances may reach or leave a biological compartment.
Interfacial interactions can alter how molecules, ions, fluids, or energy behave at the boundary between phases or materials. These interactions may affect partitioning and the ease with which a substance crosses or remains near an interface. Their influence is especially relevant when evaluating drug movement through tissues or the behavior of substances at medical-device and engineered-tissue surfaces.
Quantifying movement across an interface provides a basis for comparing how substances enter, leave, or distribute among biological compartments. Such measurements support predictions about drug absorption, distribution, and release rather than relying only on qualitative descriptions. They can also help evaluate how a treatment interacts with tissue barriers or biomaterial surfaces, contributing to safer therapies and improved delivery systems.
Clinical investigations commonly focus on cell membranes, blood vessels, tissue barriers, and biomaterial surfaces because each can regulate exchange between adjoining environments. Examining these interfaces helps connect transport behavior with specific clinical outcomes, including how a drug reaches tissues, crosses a barrier, is released from a delivery system, or interacts with a medical device.
The concept is applied to understand how treatments move across biological boundaries and how engineered materials exchange substances with the body. For drug delivery, it informs absorption, distribution, and release. For medical devices and engineered tissues, it helps characterize interactions at biomaterial surfaces. These applications support the design of systems that behave more predictably in clinical environments.